Rene Hurlemann MD PhD MBA
Professor of Psychiatry and Chair, Dept. of Psychiatry, and Associate Dean for Strategic Development, School of Medicine & Health Sciences, University of Oldenburg (Germany)
Chief Medical Officer (CMO), Karl-Jaspers Clinic, Bad Zwischenahn (Germany)
Rene Hurlemann is Chief Medical Officer (CMO) at Karl-Jaspers Clinic, a large mental health provider (600 inpatient beds, 1.200 employees) for Northwestern Germany including the city of Oldenburg. Furthermore, Rene Hurlemann is chair and full professor with the Dept. of Psychiatry in the School of Medicine & Life Sciences at University of Oldenburg, Germany. In addition, he serves the school as Associate Dean for Strategic Development. Rene Hurlemann has received doctorates from Maastricht University (PhD) and University of Bonn (MD), and his MBA from Frankfurt School of Finance & Management. As clinician scientist, he is committed to the field of precision psychiatry and has joined the World Psychiatric Association (WPA) section on Personalized Medicine in Psychiatry as well as the editorial boards of Personalized Medicine in Psychiatry (Elsevier), Social Cognitive & Affective Neuroscience (SCAN) (Oxford Academic), and Journal of Psychiatric Research (Elsevier), among others. Rene Hurlemann is head of an interdisciplinary academic research program focusing on (i) social neuroscience, (ii) digital phenotyping, (iii) brain stimulation, and (iv) phenomenological psychiatry. His research is funded by multiple sources, including German Research Foundation (DFG), German Federal Ministry of Education & Research (BMBF), and German Federal Ministry for Economic Affairs & Climate Action (BMWK). Rene Hurlemann is an affiliate investigator at the Laureate Institute for Brain Research (LIBR), Tulsa (OK, USA), co-director of the Summer School on Affective Neuroscience coordinated by Maastricht University and has joined >10 professional societies including the American College of Neuropsychopharmacology (ACNP) and the Society of Biological Psychiatry (SoBP). In addition, he serves as an international ad-hoc referee for numerous peer-reviewed journals and funding agencies as well as prize and academic appointment committees in the fields of Psychiatry and Neuroscience.
Related links:
Representative publications:
Hasan MT, Althammer F, Silva da Gouveia M, Goyon S, Eliava M, Lefevre A, Kerspern D, Schimmer J, Raftogianni A, Wahis J, Knobloch-Bollmann HS, Tang Y, Liu X, Jain A, Chavant V, Goumon Y, Weislogel J-M, Hurlemann R, Herpertz SC, Pitzer C, Darbon P, Dogbevia GK, Bertocchi I, Larkum ME, Sprengel R, Bading H, Charlet A, Grinevich V (2019) Fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103: 133 – 146 [IF 14.4]
Scheele D, Zimbal S, Feinstein JS, Delis A, Neumann C, Mielacher C, Philipsen A, Hurlemann R (2019) Treatment-resistant depression and ketamine response in a patient with bilateral amygdala damage. The American Journal of Psychiatry 176: 982 – 986 [IF 14.1]
Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH (2019) Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ – British Medical Journal 364: l1079 [IF 30.2]
Lieberz J, Shamay-Tsoory SG, Saporta N, Esser T, Kuskova E, Stoffel-Wagner B, Hurlemann R, Scheele D (2021) Loneliness and the social brain: how perceived social isolation impairs human interactions. Advanced Science 8: e2102076 [IF 17.5]
Morr M, Noell J, Sassin D, Daniels J, Philipsen A, Becker B, Stoffel-Wagner B, Hurlemann R, Scheele D (2022) Lonely in the dark: Trauma memory and sex-specific dysregulation of amygdala reactivity to fear signals. Advanced Science 9: e2105336 [IF = 15.1]
Abbreviations: IF, Journal Impact Factor
Latest book:
Hurlemann R & Grinevich V (2018) Behavioral Pharmacology of Neuropeptides: Oxytocin (Current Topics in Behavioral Neurosciences, Volume 35) Springer [978-3319637389] Link